StonvexLoading…
StonvexStonvexStonvexCore line items from HST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.65B | $6.11B | $4.51B | $3.18B |
Operating Income | $319.00M | $855.00M | $663.00M | $562.00M |
Net Income | $494.00M | $765.00M | $630.00M | $469.00M |
EPS (Diluted) | $0.72 | $1.10 | $0.91 | $0.67 |
Total Assets | $13.15B | $13.05B | $13.04B | $12.96B |
Total Liabilities | $6.14B | $6.32B | $6.23B | $6.18B |
Cash & Equivalents | $1.70B | $768.00M | $539.00M | $490.00M |
Free Cash Flow OCF − CapEx | $291.00M | $1.23B | $783.00M | $640.00M |
Shares Outstanding | 684.90M | 687.80M | 687.70M | 687.50M |